Natco Pharma falls despite the company receiving approval for the generic version of ledipasvir+sofosbuvir combination from the Drugs Controller General (India).
Subscribe To Our Free Newsletter |
Natco Pharma falls despite the company receiving approval for the generic version of ledipasvir+sofosbuvir combination from the Drugs Controller General (India).
Subscribe To Our Free Newsletter |
EvoLve theme by Theme4Press • Powered by WordPress & Rakesh Jhunjhunwala Latest Stock Market News
The Most Valuable Commodity Is Information!